They’re going Amazon brand names with the drug names now #kisunla

Alzheimer mit 57: Patientin hofft auf neues Medikament Alzheimer ist unheilbar. Ein neues Mittel macht Patienten Hoffnung. Es soll das Fortschreiten der Krankheit verlangsamen. Eine Betroffene erzählt von ihrer Erfahrung - und was sie noch alles vorhat.

Berliner Charité
#Alzheimer mit 57 Jahren
#Donanemab #Kisunla #Demenz
www.badische-zeitung.de/alzheimer-mi...

#Kisunla on the other hand?

#Trump's likely getting #Kisunla or #Leqembi infusions, every 2-4 weeks, requiring frequent MRIs to detect possible ARIA(s)—brain swelling or bleeds🧠 He has #dementia (like his sister Maryanne and cousin, John Walter) or possibly #Alzheimer's (like his father).

@epistemiccrisis.bsky.social

Does Donald Trump have ALZHEIMERS ?

Look at his hands the bruising they look like they’re rotting, is this where the DRIP goes in ?

The DRUGS used in this treatment #LEQEMBI & #KISUNLA Can cause fluid leakage on the brain.

#POTUS47 has unexplained #MRI’s WHY ?

The American People Must Know

#leqembi #kisunla

🚨 BREAKING: Did a Medical Pro Crack the Health Crisis Secret/Alzheimer’s Code? A Deep Dive into the One Story MAGA Cannot Escape

open.substack.com/pub/deanblun...
#Trump #Kisunla #Alzheimers

Just one day.

Please just 24hrs without this absolute cancer and his faux announcement bullshit.

Thank fuck the clock is ticking on this prick

#Kisunla

“This dementia patient has three to five months left to live”—The educated opinion of a physical therapist with a doctorate in his field.

I’m pulling for an early Christmas present for the world.

#Pink #ProudBlue #tRumpStroke #Kisunla

He’s likely on new Alzheimer’s infusion drugs (every 2–4 weeks) with strict protocols, including 6-month medical exams and brain MRIs. These treatments are only for early Alzheimer’s, but Trump would insist on them whether he qualified or not. #Leqembi #Kisunla #caregiver

#Trump wandering around Japanese Prime Minister's hall like a Roomba...
Bruises to back of hand
#Kisunla #dementia treatment IV drug
Side effects incl. stroke-like symptoms= face droop
#MRI (to check for brain bleeds)

#Kisunla
Infusion

#Trump's Bruised hands probably result of monthly IV infusion
of #Kisunla for treatment of #Alzheimers. (Look it up)

Trump's father, Fred had Alzheimers.

Alzheimer’s research: Cutting through the noise to find the signal A closer look at how clinical trials for Alzheimer’s have evolved and what this means for patients and sites, with Medidata and Cogstate.

#Alzheimersdisease #Dementia #NeurodegenerativeDiseases #Alzheimersresearch #neurodegeneration #AlzheimersResearchUK #Eisai #Leqembi #Roche #trontinemab #ADpatients #cognitivedecline #EliLilly #Kisunla #BrainHealthMatters #brainhealth #clinicaltrials #Alzheimersdiseaseresearch
zurl.co/8DRVI

The drug #Kisunla from #EliLilly, which has a certain inhibitory effect on #Alzheimers, has been given the green light by the #European Commission

Kisunla contains an antibody that can partially slow progression of the #disease in patients who are in early stages of the disease.

The European Commission has authorized #Kisunla, marking a new era in #Alzheimer's treatment and accelerating global innovation. This milestone expands access for patients and families, enabling early detection and treatments that help slow decline. @elilillyandcompany.bsky.social
bit.ly/46mYY9M

Eli Lilly Secures Approval for Kisunla, A Breakthrough in Alzheimer's Treatment in Europe Eli Lilly's Kisunla (donanemab) gains European Commission authorization for early-stage Alzheimer's, presenting a promising treatment option.

Eli Lilly Secures Approval for Kisunla, A Breakthrough in Alzheimer's Treatment in Europe #None #Alzheimer's #Kisunla #Donanemab

Christian Haass @dzne.science berichtet von den heute verfügbaren Antikörpertherapien #Lecanemab / #Leqembi, #Donanemab / #Kisunla und #Aducunumab / #Aduhelm, die von Beginn an mithilfe von #Tierversuche n entwickelt wurden, und wie neue Technologien die Forschung seines Teams heute verändern.

Eli Lilly's Kisunla Shows Sustained Benefits in Alzheimer's Disease Over Three Years Eli Lilly's Kisunla (donanemab-azbt) demonstrates continued benefits over three years for Alzheimer's patients, emphasizing the value of early intervention strategies.

Eli Lilly's Kisunla Shows Sustained Benefits in Alzheimer's Disease Over Three Years #United_States #Indianapolis #Alzheimer's_Disease #Eli_Lilly #Kisunla

#EliLilly's appeal of a decision by the #EMA's human medicines committee not to approve its #Alzheimers disease therapy #Kisunla has paid off, albeit with a narrower label than it originally sought.

pharmaphorum.com/news/lillys-...

Eli Lilly’s Alzheimer’s drug Kisunla gets positive CHMP opinion Investing.com -- Eli Lilly (NYSE:LLY)’s Alzheimer’s treatment Kisunla (donanemab) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), recommending the drug for the treatment of early symptomatic Alzheimer’s disease. The European Commission is expected to make a final regulatory decision on donanemab in the coming months, following this recommendation. The CHMP based its positive opinion primarily on data from two clinical trials: TRAILBLAZER-ALZ 2 and TRAILBLAZER-ALZ 6. These trials provided the evidence that supported the committee’s recommendation for approval. If approved by the European Commission, Kisunla would become available as a treatment option for patients with early symptomatic Alzheimer’s disease across European Union member states. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks – 6 model portfolios fueled by AI stock picks with a stellar performance this year.. In 2024 alone, ProPicks' AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if LLY is on your watchlist, it could be very wise to know whether or not it made the ProPicks lists.

Click Subscribe #EliLilly #Alzheimers #Kisunla #CHMP #Pharmaceuticals

FDA approves new dosing of Lilly’s Alzheimer’s drug to lower brain swelling risks Lilly's Alzheimer's drug Kisunla gets FDA approval for new dosing regimen reducing brain swelling risk by 41%.

The FDA approved a new dosing of Lilly’s #Alzheimers drug #Kisunla to lower brain swelling risks known as ARIA-E, based on a new Phase 3 study where modified dosing caused ARIA-E in 14% of patients compared to 24% on original dosing. More in my story for @endpts.com endpoints.news/fda-approves...

Eli Lilly's Kisunla Gains FDA Approval with Updated Dosing for Alzheimer's Treatment Eli Lilly's Kisunla has received FDA approval for an updated dosing regimen, enhancing patient safety while targeting early Alzheimer's disease effectively.

Eli Lilly's Kisunla Gains FDA Approval with Updated Dosing for Alzheimer's Treatment #USA #Indianapolis #Alzheimer's #Lilly #Kisunla

Final draft guidance finds benefits of 2 Alzheimer’s treatments remain too small to justify the additional costs to the NHS The benefits of Alzheimer’s treatments donanemab and lecanemab remain too small to justify the additional costs

#NICE #NICEFAD #NICEfinaldraftguidance #Alzheimerstreatments #NHS #donanemab #Kisunla #EliLilly #lecanemab #Leqembi #Eisai #negativedraftrecommendations #mildcognitiveimpairment #milddementia #Alzheimersdisease #NHSresources #NICEassessments #cognitiveimpairment
www.nice.org.uk/news/article...

Eli Lilly's Kisunla Approved in Australia for Alzheimer's Treatment Eli Lilly's Kisunla has received marketing authorization in Australia, offering hope to those with early symptomatic Alzheimer's disease. This landmark treatment targets amyloid plaques, potentially improving lives of many Australians.

Eli Lilly's Kisunla Approved in Australia for Alzheimer's Treatment #Indianapolis #Australia #Alzheimer's_Disease #Eli_Lilly #Kisunla

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended against granting the marketing authorisation of #donanemab ( #Kisunla ) in the treatment of the mild dementia stage of Alzheimer’s disease across the EU and EEA.
www.ema.europa.eu/en/medicines...

If you remain curious about the hope of those new #Alzheimer’s medications – and who of us doesn’t remain curious?! – then please take a couple minutes to listen to this NPR story.

www.npr.org/sections/sho...
 
#SoManyGoodbyes #dementia #caregivers #ENDALZ #lecanemab #donanemab #Leqembi #Kisunla

"That hope is so key, Julie."

I was honored to share about this new opportunity for hope.
And I was beyond honored to share the Hubble family's story.

www.kare11.com/article/news...

#lecanemab #donanemab #Leqembi #Kisunla #Alzheimers #dementia #caregivers #ENDALZ